title: Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: Relationship with prognosis.
abstract: Matrix metalloproteinases (MMPs), a family of proteolytic enzymes produced by both stromal and tumor cells, appear to have a key role in the events leading to local invasion and metastasis by malignant neoplasms. In the present study, we evaluated the role of MMP-2, squamous cell carcinoma antigen (SCCA), and tissue polypeptide - specific antigen (TPS) in cervical neoplasia. Using Western blotting and enzyme immunoassay (EIA), we analyzed 50 patients with cervical carcinoma (CC) and 25 normal controls for expression of MMP-2 in tissue cell lysates. We also quantified SCCA and TPS with microparticle immunoassay and EIA, respectively. The results were correlated with human papilloma virus (HPV) infection, clinicopathological findings, and disease outcome. The cutoff point for each marker was estimated from receiver operating characteristic curves. Logistic regression analysis was performed to estimate the odds ratio (OR) and 95% confidence interval (CI) for each marker. MMP-2, SCCA, and TPS protein expression were significantly higher in patients with CC than in normal controls. While TPS was the best marker for discriminating between patients and controls, MMP-2 was associated with an advanced tumor stage (OR, 13.9 [95% CI, 1.4-133.9]) and poor histological grade (OR, 10.2 [95% CI, 1.7-60.5]). Moreover, independent of the effect of an advanced CC stage and grade, the patients' age, and the presence of HPV infection, MMP-2 was considered a strong predictor for CC recurrence (OR, 8.1 [95% CI, 1.3- 49.1]). Tissue markers may be used to select high-risk patients for early detection of and adjuvant therapy for recurrence. Our MMP-2 findings are particularly relevant to the development of protease inhibitors as a new cancer therapy approach.
authors.affiliation: Biochemistry Department, Ain Shams Faculty of Medicine, Cairo, Egypt.
authors.forename: Maha Imam
authors.initials: MI
authors.lastname: Ahmed
authors.forename: Eman-El
authors.initials: EE
authors.lastname: Salahy
authors.forename: Hassan
authors.initials: H
authors.lastname: Tawfiq
authors.forename: Ali
authors.initials: A
authors.lastname: Khalifa
authors.forename: Manal M
authors.initials: MM
authors.lastname: Hassan
mesh_terms: D000367:Age Factors; D000951:Antigens, Neoplasm / Q000096:biosynthesis*; D015415:Biomarkers / Q000378:metabolism; D015153:Blotting, Western; D002277:Carcinoma / Q000175:diagnosis / Q000378:metabolism*; D004534:Egypt; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D016015:Logistic Models; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis*; D009369:Neoplasms / Q000378:metabolism; D016017:Odds Ratio; D027383:Papillomaviridae / Q000235:genetics; D010455:Peptides / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D011379:Prognosis; D012372:ROC Curve; D012008:Recurrence; D012306:Risk; D012680:Sensitivity and Specificity; D015843:Serpins / Q000096:biosynthesis*; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000378:metabolism*
chemical_list: D000951:Antigens, Neoplasm; D015415:Biomarkers; D010455:Peptides; D015843:Serpins; C051072:squamous cell carcinoma-related antigen; C089984:tissue polypeptide specific antigen; D020778:Matrix Metalloproteinase 2